Real-time enrollment status for this transthyretin cardiac amyloidosis clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 9:52 AM UTC
| NCT Number | NCT06978660 |
| Recruiting Status | Recruiting |
| Condition | Transthyretin Cardiac Amyloidosis |
| Phase | Clinical Trial |
| Target Enrollment | 2,200 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Idoven 1903 S.L. |
| Last Updated on CT.gov | June 23, 2026 (2 weeks ago) |
As of July 13, 2026: Clinical trial NCT06978660 is currently recruiting participants. This clinical trial study for transthyretin cardiac amyloidosis is actively seeking new participants at 1 location across the United States. The study is sponsored by Idoven 1903 S.L.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06978660 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06978660 was last updated 2 weeks ago (June 23, 2026). HelloStudys verifies this status automatically.